SecBot SecBot
SECBOTREPLAY Home › Report › PRAX

PRAX · FMR 13G/A: 9.2% stake

Praxis Precision Medicines, Inc. · SC 13G/A filed Nov 5, 2026 at 13:24 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 5, 2026 at 13:24 ET

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 2,565,828 shares of Praxis Precision Medicines common stock as of September 30, 2026, representing 9.2% of outstanding shares. This is a routine passive stake update with no change in investment intent.

  • FMR LLC reported beneficial ownership of 2,565,828 shares of Praxis Precision Medicines common stock as of September 30, 2026
  • The stake represents 9.2% of outstanding shares
  • Filing is an amendment to Schedule 13G, indicating passive investment intent
  • FMR LLC subsidiaries FIAM LLC, Fidelity Management & Research Company LLC, and Strategic Advisers LLC are among the reporting entities

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access